Orskov Lindhardt B, Ulrich K, Ryder L, Dickmeiss E, Sørensen H, Jørgensen J, Jersild C, Grunnet N
Vox Sang. 1986;51 Suppl 1:9-14. doi: 10.1111/j.1423-0410.1986.tb01987.x.
The Organon Teknika Vironostika anti-HTLV-III/LAV test was evaluated in three Danish blood banks. The evaluation comprised in total 3,940 consecutive donors. In all three blood banks the tests were carried out exactly according to the manufacturer's instructions, using a low cut-off value defined as (4N + P)/5, where N and P are means of optical densities of known negative and positive samples. By this method the overall frequency of repeatably positive samples was 0.30%. When tested by Western blot, however, none of these samples were shown to contain specific antibodies against HTLV-III/LAV proteins. When testing different categories of patients, only sera containing HLA antibodies gave rise to false-positive reactions. Finally, important differences in the results were observed regarding sample preparation, single or dual wavelength optical density readings, and the experience of the technical staff.
对欧加农技术公司的Vironostika抗HTLV - III/LAV检测试剂在丹麦的三家血库进行了评估。此次评估共计3940名连续供血者。在所有三家血库中,检测均严格按照制造商的说明进行,采用定义为(4N + P)/5的低临界值,其中N和P分别为已知阴性和阳性样本的光密度均值。通过这种方法,可重复性阳性样本的总体频率为0.30%。然而,经蛋白印迹法检测,这些样本均未显示含有针对HTLV - III/LAV蛋白的特异性抗体。在检测不同类别的患者时,只有含有HLA抗体的血清会产生假阳性反应。最后,在样本制备、单波长或双波长光密度读数以及技术人员的经验方面,观察到了结果上的重要差异。